TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 45 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,478,000 | +245.3% | 1,485,000 | +236.7% | 0.00% | – |
Q3 2020 | $428,000 | +3466.7% | 441,000 | +3292.3% | 0.00% | – |
Q3 2019 | $12,000 | -99.7% | 13,000 | -99.6% | 0.00% | -100.0% |
Q2 2017 | $3,742,000 | +0.8% | 3,478,000 | +0.2% | 0.00% | 0.0% |
Q1 2017 | $3,712,000 | +11.2% | 3,471,000 | +14.0% | 0.00% | 0.0% |
Q4 2016 | $3,338,000 | +66.0% | 3,046,000 | +80.7% | 0.00% | +100.0% |
Q3 2016 | $2,011,000 | -22.5% | 1,686,000 | -18.4% | 0.00% | -50.0% |
Q2 2016 | $2,594,000 | -18.2% | 2,065,000 | -4.6% | 0.00% | 0.0% |
Q1 2016 | $3,172,000 | +5.0% | 2,165,000 | +12.5% | 0.00% | 0.0% |
Q4 2015 | $3,022,000 | +9.8% | 1,925,000 | -4.9% | 0.00% | 0.0% |
Q3 2015 | $2,752,000 | +49.7% | 2,025,000 | +52.7% | 0.00% | +100.0% |
Q2 2015 | $1,838,000 | +135.9% | 1,326,000 | +152.6% | 0.00% | 0.0% |
Q1 2015 | $779,000 | +63.0% | 525,000 | +50.0% | 0.00% | – |
Q4 2014 | $478,000 | +7.9% | 350,000 | +1.4% | 0.00% | – |
Q3 2014 | $443,000 | +73.0% | 345,000 | +72.5% | 0.00% | – |
Q2 2014 | $256,000 | +3.6% | 200,000 | +2.6% | 0.00% | – |
Q1 2014 | $247,000 | +29.3% | 195,000 | +8.3% | 0.00% | – |
Q4 2013 | $191,000 | +2.1% | 180,000 | 0.0% | 0.00% | – |
Q3 2013 | $187,000 | -7.4% | 180,000 | -6.2% | 0.00% | – |
Q2 2013 | $202,000 | – | 192,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|